NEFL and Alzheimer disease: Although the combination biomarker plasma NFL/Aβ1–42 exhibited slower dynamics than CSF Aβ1–42 concentrations, differences were observed at early stages of AD when compared to those observed with CSF t-Tau and p-Tau181 concentrations.